Predicted to enable identical protein binding activity. Predicted to act upstream of or within negative regulation of ERK1 and ERK2 cascade; negative regulation of fat cell differentiation; and negative regulation of fibroblast proliferation. Predicted to be active in extracellular space. Orthologous to human C1QL4 (complement C1q like 4). [provided by Alliance of Genome Resources, Apr 2022]